[W8] Gene Therapy Flashcards

(30 cards)

1
Q

What is gene therapy?

A

Replacement or repair of defective genes to treat or prevent disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the broader definition of gene therapy?

A

Treatment of genetic disorders by modifying human body cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is gene editing?

A

Precise alteration (insertion, deletion, or replacement) of DNA using engineered nucleases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the difference between gene therapy and gene editing?

A

Gene therapy replaces an entire gene; gene editing targets specific regions within genes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What factors influence gene therapy success?

A
  • Disease’s genetic basis
  • Target tissue/cell type
  • Delivery route
  • Expression duration
  • Gene regulation
  • Cell/tissue specificity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What must a therapeutic gene achieve in cells?

A

Correct timing and level of expression in the right target cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which disease type is most commonly targeted by gene therapy?

A

Cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Are many diseases linked to single genes?

A

No, most have complex or multiple genetic components.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the two main categories of gene delivery methods?

A
  • Viral-mediated delivery (~75%)
  • Non-viral-mediated delivery (~25%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What factors influence the choice of delivery method?

A
  • Delivery efficiency
  • Gene size
  • Duration of expression
  • Safety profile
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is a replication-deficient virus?

A

A virus modified to remove genes for replication/pathogenicity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is viral tropism useful in gene therapy?

A

It allows targeting of specific tissues/organs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is a risk of using viral vectors?

A

Reversion to wild-type virus or off-target effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is naked DNA delivery?

A

Direct injection of DNA (e.g., into muscle); low efficiency, rapidly degraded systemically.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are liposomes?

A

Lipid-based carriers for DNA/mRNA delivery; safe but inefficient and rapidly cleared.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the challenges of non-viral delivery?

A
  • Cell entry
  • Nuclear transport
  • Efficient transcription
17
Q

How do adenovirus-based vaccines work?

A

Deliver the gene for an antigen (e.g., SARS-CoV-2 spike protein) into host cells for expression.

18
Q

How do liposome-based mRNA vaccines work?

A

Deliver mRNA encoding spike protein into the cytoplasm; no need for nuclear entry.

19
Q

What is CAR-T cell therapy?

A

A gene therapy where a patient’s T-cells are modified to express chimeric antigen receptors (CARs) that target cancer cells.

20
Q

Name three genome editing systems.

A
  • Zinc Finger Nucleases (ZFNs)
  • TALENs
  • CRISPR-Cas9
21
Q

What are the two approaches to genome editing?

A
  • Protein-based
  • RNA-based
22
Q

What is CRISPR?

A

A prokaryotic immune mechanism using guide RNA and Cas9 nuclease to target and cut specific DNA sequences.

23
Q

What does Cas9 do?

A

It is an endonuclease that creates double-stranded breaks at target DNA sites guided by RNA.

24
Q

What is a PAM sequence?

A

A short DNA motif required for Cas9 to bind and cleave target DNA.

25
What disease was CRISPR approved to treat in 2023 (UK/US)?
Sickle cell disease.
26
What is the CRISPR target for treating sickle cell and thalassaemia?
The BCL11A gene – represses fetal haemoglobin expression.
27
How does editing BCL11A help?
Restores fetal haemoglobin production to compensate for defective adult haemoglobin.
28
What are major limitations of CRISPR?
* Off-target effects * Delivery challenges * PAM site restrictions * Cas9 immunogenicity
29
Why is delivery a key challenge?
The system requires delivery of: * Cas9 gene/protein * Guide RNA * New DNA template (if needed)
30
What is the cost of CRISPR-based treatments in the UK?
Around £1 million per treatment.